1-14 of 14
Guido Nador
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Updated Results of a Matching-Adjusted Indirect Comparison of Elranatamab Versus Teclistamab in Patients with Triple-Class Exposed/Refractory Multiple Myeloma

Isha Mol, Yannan Hu, Thomas W. LeBlanc, Joseph C. Cappelleri, Haitao Chu, Guido Nador, Didem Aydin, Isabel Perez-Cruz, Patrick Hlavacek
Journal: Blood
Blood (2024) 144 (Supplement 1): 3367.
https://doi.org/10.1182/blood-2024-206951
Published: 2024
Journal Articles

An Indirect Comparison of Elranatamab's Progression-Free Survival, Duration of Response, and Overall Survival from MagnetisMM-3 Versus Real-World External Control Arms in Triple-Class Refractory Multiple Myeloma

Luciano J. Costa, Thomas W. LeBlanc, Hans Tesch, Pieter Sonneveld, Sarasa M.A. Johnson, Francis Vekeman, Patrick Hlavacek, Aster Meche, Paul Cislo, David Hughes, Guido Nador, Marco DiBonaventura
Journal: Blood
Blood (2024) 144 (Supplement 1): 2401.
https://doi.org/10.1182/blood-2024-203920
Published: 2024
Journal Articles

Patient-Reported Outcomes Among Patients with Triple-Class Refractory Multiple Myeloma in Real-World Clinical Practice: A Prospective, Multi-Site Observational Study - Interim Results

Charis Charalampous, Shaji Kumar, Ricardo D. Parrondo, Saurabh Chhabra, Madhu Nagaraj, Mei Sheng Duh, Priyanka J. Bobbili, Aolin Wang, Jingyi Chen, Manasi Mohan, Patrick Hlavacek, Rickard Sandin, Joseph C. Cappelleri, David Hughes, Guido Nador, Marco DiBonaventura
Journal: Blood
Blood (2024) 144 (Supplement 1): 3770.
https://doi.org/10.1182/blood-2024-204005
Published: 2024
Journal Articles

Updated Results of a Matching-Adjusted Indirect Comparison of Elranatamab Versus Physician's Choice of Treatment in Patients with Triple-Class Exposed/Refractory Multiple Myeloma

Isha Mol, Yannan Hu, Thomas W. LeBlanc, Joseph C. Cappelleri, Haitao Chu, Guido Nador, Didem Aydin, Isabel Perez-Cruz, Patrick Hlavacek
Journal: Blood
Blood (2024) 144 (Supplement 1): 7028.
https://doi.org/10.1182/blood-2024-206856
Published: 2024
Journal Articles

A Matching-Adjusted Indirect Comparison of the Efficacy of Elranatamab and Teclistamab in Patients with Triple-Class Exposed/Refractory Multiple Myeloma

Isha Mol, Yannan Hu, Thomas W LeBlanc, Joseph C Cappelleri, Haitao Chu, Guido Nador, Didem Aydin, Alex Schepart, Patrick Hlavacek
Journal: Blood
Blood (2023) 142 (Supplement 1): 2015.
https://doi.org/10.1182/blood-2023-186409
Published: 2023
Journal Articles

A Matching-Adjusted Indirect Comparison of the Efficacy of Elranatamab Versus Physician's Choice of Treatment in Patients with Triple-Class Exposed/Refractory Multiple Myeloma

Isha Mol, Yannan Hu, Thomas W LeBlanc, Joseph C Cappelleri, Haitao Chu, Guido Nador, Didem Aydin, Alex Schepart, Patrick Hlavacek
Journal: Blood
Blood (2023) 142 (Supplement 1): 6731.
https://doi.org/10.1182/blood-2023-185920
Published: 2023
Journal Articles

A Matching-Adjusted Indirect Comparison of the Efficacy of Elranatamab Versus Physician's Choice of Treatment Among Patients with Triple-Class Exposed/Refractory Multiple Myeloma in Canada

Isha Mol, Yannan Hu, Fiorella Fanton-Aita, Phu Vinh On, Hicham Gonzalez, Richard LeBlanc, Donna Reece, Jiandong Su, Engin Gul, Alissa Visram, Joseph C Cappelleri, Haitao Chu, Guido Nador, Patrick Hlavacek
Journal: Blood
Blood (2023) 142 (Supplement 1): 6738.
https://doi.org/10.1182/blood-2023-186559
Published: 2023
Journal Articles

Patient-Reported Outcomes Among Patients with Triple-Class Refractory Multiple Myeloma in Real-World Clinical Practice: A Prospective, Multi-Site Observational Study

Charalampos Charalampous, Shaji Kunnathu Kumar, Ricardo Parrondo, Saurabh Chhabra, Mei Sheng Duh, Priyanka Bobbili, Aolin Wang, Jingyi Chen, Manasi Mohan, Patrick Hlavacek, Jinma Ren, Alex Schepart, Guido Nador, Marco DiBonaventura
Journal: Blood
Blood (2023) 142 (Supplement 1): 6727.
https://doi.org/10.1182/blood-2023-180984
Published: 2023
Journal Articles

An Indirect Comparison of Elranatamab's Progression-Free Survival and Overall Survival from Magnetismm-3 Versus Real-World External Control Arms in Triple-Class Refractory Multiple Myeloma

Luciano Costa, Thomas W LeBlanc, Hans Tesch, Pieter Sonneveld, Ryan Kyle, Liliya Sinyavskaya, Patrick Hlavacek, Aster Meche, Jinma Ren, Alex Schepart, Didem Aydin, Guido Nador, Marco DiBonaventura
Journal: Blood
Blood (2023) 142 (Supplement 1): 6716.
https://doi.org/10.1182/blood-2023-180848
Published: 2023
Journal Articles

Elective Vs Non-Elective Hospital Admissions By Patients with Multiple Myeloma in England 2014 - 2018

Karthik Ramasamy, MD PhD, Spyros Kolovos, PhD, Guido Nador, MD, Rosemarie Finley, Matthew Streetly, MD, Bhuvan Kishore, Neil K Rabin, MD, Andrew D Chantry, PhD MD, Kwee Yong, MD PhD, John Ashcroft, Stella Bowcock, MD BA, FRCP, FRCPath, MA, Mark T Drayson, Daniel Prieto-Alhambra, PhD MD, Cyrus Cooper, OBE, DL, FMedSci, Muhammad Kassim Javaid, MD PhD, Rafael Pinedo-Villanueva, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4743.
https://doi.org/10.1182/blood-2018-99-114736
Published: 2018
Journal Articles

A Phase II Multi-Center Trial Of Pentostatin Plus Cyclophosphamide With Ofatumumab (PCO) In Older Previously Untreated Chronic Lymphocytic Leukemia (CLL) Patients

Marco Montillo, MD, Davide Rossi, Marina Motta, MD, Giulia Quaresmini, MD, Marianna Rossi, MD, Marta Coscia, MD, PhD, Antonella Anastasia, MD, Fausto Rossini, MD, Agostino Cortelezzi, MD, Guido Nador, MD, Lydia Scarfò, MD, Roberto Cairoli, MD, Daniela Dal Ceggio, MD, Lorenzo De Paoli, MD, Enrica Morra, MD, Alessandro Rambaldi, MD, Ester Orlandi, MD, Massimo Massaia, MD, Alessandra Tedeschi, MD
Journal: Blood
Blood (2013) 122 (21): 4177.
https://doi.org/10.1182/blood.V122.21.4177.4177
Published: 2013
Journal Articles

A Case of Massive Intracerebral Haemorrage in Advanced Myelofibrosis Due to Atypical Metaplasia.

Marianna Caramella, Cristina Gabutti, Cecilia Del Curto, Cristina Campidelli, Guido Nador, Ester Pungolino, Enrica Morra, MD
Journal: Blood
Blood (2009) 114 (22): 4988.
https://doi.org/10.1182/blood.V114.22.4988.4988
Published: 2009
Journal Articles

Prognostic Significance of CD33, CD34 and CD117 Expression on Bone Marrow Blasts of Patients with Myelodysplastic Syndromes.

Guido Nador, Alfredo Molteni, Clara Cesana, Michele Nichelatti, Barbara Scarpati, Roberto Cairoli, Luciana Barbarano, Annamaria Nosari, Enrica Morra
Journal: Blood
Blood (2007) 110 (11): 4604.
https://doi.org/10.1182/blood.V110.11.4604.4604
Published: 2007
Journal Articles

Complications of Central Venous Catheters in Patients with Hematologic Malignancy: Analysis of Risk Factors.

Annamaria Nosari, MD, Guido Nador, MD, Andrea de Gasperi, MD, Nichelatti Michele, PhD, Anghilieri Michela, MD, Cozzi Paola, MD, Mancini Valentina, MD, Luchesini Camilla, MD, Ricci Francesca, MD, Ciapanna Dennis, MD, Ravelli Erica, MD, Cantoni Silvia, MD, Morra Enrica, MD.
Journal: Blood
Blood (2004) 104 (11): 4520.
https://doi.org/10.1182/blood.V104.11.4520.4520
Published: 2004